Company / Gross Margin
AVADEL PHARMACEUTICALS PLC Gross Margin History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
91.0%
FY2024
5-year range
91.0% / 97.0%
FY2023-FY2024
Trend
-6.2%
vs FY2023
Sector context
#1 of 28
Health Care
What the data says
Among 28 Health Care companies, AVADEL PHARMACEUTICALS PLC is in the top 4% for gross margin.
Based on SEC 10-K filings.
91.0% in FY2024. Ranks 1st among 28 companies in Health Care.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Top 4% in Health CareTop 4% of 28This company 91.0% Sector average 60.3%
▼
+50.9% above sector average
Key checks
Key Insights
- In FY2024, gross margin decreased 6.2% year-over-year.
- Currently 30.7pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 91.0% | -6.2% |
| FY2023 | 97.0% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026